A randomized prospective double-blind placebo-controlled study of gallopamil, calcium antagonist of the verapamil type, in stable cyclosporine-treated renal transplant recipients

Transplant Proc. 2002 Aug;34(5):1767-70. doi: 10.1016/s0041-1345(02)03059-2.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blood Pressure / drug effects*
  • Calcium Channel Blockers / therapeutic use
  • Creatinine / blood
  • Cyclosporine / blood
  • Cyclosporine / therapeutic use*
  • Double-Blind Method
  • Gallopamil / therapeutic use*
  • Humans
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation / physiology*
  • Placebos
  • Prospective Studies
  • Urea / blood
  • Uric Acid / blood
  • Verapamil / therapeutic use

Substances

  • Calcium Channel Blockers
  • Immunosuppressive Agents
  • Placebos
  • Uric Acid
  • Gallopamil
  • Cyclosporine
  • Urea
  • Creatinine
  • Verapamil